Vasileios Askoxylakis

Author

Heidelberg University ORCID

Also Known As

Naxerova, Kamila, V Askoxylakis, V. Askoxylakis, Vasileios Askoxylakis

112

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University German Cancer Research Center Massachusetts General Hospital Harvard University Merrimack Pharmaceuticals (United States)

About

Vasileios Askoxylakis is an author at Heidelberg University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	620
2	Engineering	3	3	549
3	Health Sciences	2	2	101
4	Natural Sciences	1	1	10
5	Nursing	1	1	44

Vasileios Askoxylakis

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green Jessica A. Carr, Daniel Franke, Justin R. Caram, Proceedings of the National Academy of Sciences	2018	660
Solid stress and elastic energy as measures of tumour mechanopathology Hadi T. Nia, Hao Liu, Giorgio Seano, Nature Biomedical Engineering MechanobiologyNonlinear ElasticitySolid StressEngineeringElasticity (Physics)	2016	420
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, Proceedings of the National Academy of Sciences	2016	350
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption Costas Arvanitis, Vasileios Askoxylakis, Yutong Guo, Proceedings of the National Academy of Sciences	2018	229
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium Giorgio Seano, Hadi T. Nia, Kyrre E. Emblem, Nature Biomedical Engineering Neuro-oncologySolid StressTumor InnervationStressBrain Tumours	2018	192
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín, Journal for ImmunoTherapy of Cancer	2022	147
Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy Eleanor I Ager, Sergey V. Kozin, Nathaniel D. Kirkpatrick, JNCI Journal of the National Cancer Institute	2015	129
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation David P. Kodack, Vasileios Askoxylakis, Gino B. Ferraro, Science Translational Medicine	2017	108
A New Prostate Carcinoma Binding Peptide (DUP-1) for Tumor Imaging and Therapy Sabine Zitzmann, Walter Mier, Arno Schad, Clinical Cancer Research	2005	82
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment Vasileios Askoxylakis, Gino B. Ferraro, David P. Kodack, JNCI Journal of the National Cancer Institute	2015	80

Page 1